Borman Mark P 4
4 · U.S. Stem Cell, Inc. · Filed Oct 26, 2018
Insider Transaction Report
Form 4
Borman Mark P
Director
Transactions
- Other
Common Stock
2018-10-19$0.03/sh+526,918$14,227→ 526,942 total(indirect: By Trust)
Footnotes (1)
- [F1]Acquired in lieu of payment of costs incurred as a member of the Board of Directors (from 2009 to present) totaling $14,471.66.